TET2 and head and neck squamous cell carcinoma: In the Cancer Genome Atlas cohort of HNSCC, TET1, TET2, and TET3 mutations were identified in nine (1.8%), eight patients (1.6%), and eight patients (1.6%) of 510 patients, respectively 17.